TREA

86353815 - PHARMACOSCOPY

Follow

Information

  • Trademark
  • 86353815
  • Serial Number
    86353815
  • Registration Number
    4925065
  • Filing Date
    July 31, 2014
    10 years ago
  • Registration Date
    March 29, 2016
    8 years ago
  • Transaction Date
    November 22, 2022
    2 years ago
  • Status Date
    October 14, 2022
    2 years ago
  • Published for Opposition Date
    January 12, 2016
    8 years ago
  • Location Date
    March 29, 2016
    8 years ago
  • Status Code
    710
  • Current Location
    PUBLICATION AND ISSUE SECTION
    Employee Name
    CLYBURN, CARLA DIONNE
  • Attorney Docket Number
    AOV0052TUS
    Attorney Name
    Alison M. Caless
    Law Office Assigned Location Code
    M10
  • Owners
Information
Mark Drawing Code
4000
Mark Identification
PHARMACOSCOPY
Case File Statements
  • GS0091: Apparatus, namely, cell culture dishes used for cell culture, testing and/or detecting effects of drugs on cell types, in particular cells originating from blood or other tissues; scientific, optical, measuring and monitoring apparatus and instruments, namely, cell sorting devices, microscopes, photometers, and digital cameras; electric apparatus and instruments, namely, automated epi-fluorescent and confocal fluorescent microscopes for use in laboratories for medical purposes; computer-aided analysis apparatus and installations for receiving, processing, transmitting and displaying data constructed therefrom; computer hardware and computer software for processing, displaying, and interpreting data, in particular for scientific and medical purposes; test microtiter plates, namely, laboratory medical equipment for cell culture, testing, and/or detecting effects of drugs on cell types
  • GS0051: Biochemical or chemical products for use in high-throughput screening assays for use in medical diagnosis and treatment; pharmaceutical and biochemical substances and preparations, in particular reagents for medical diagnosis of human diseases such as cancer, inflammation, and immune disorders; biochemical reagents for use in high-through put screening assays or chemical reagents for in vitro use in laboratories for medical purposes; chemical reagents for use in high-through put screening assays for in vitro use in laboratories for medical purposes; biochemical reagents for use in high-through put screening assays, or chemical reagents for use in cell culture, testing, and/or detecting effects of drugs on cells, in particular cells originating from blood or other tissues for medical use; diagnostic products, namely, reagents for medical purposes
  • GS0011: Biochemical products for use in high-throughput screening assays or chemicals for use in industry and science; biochemical reagents or chemical reagents for in vitro use in laboratories for scientific use; biochemicals or chemical reagents for use in cell culture, testing, and/or detecting effects of drugs on cells other than for medical or veterinary use, in particular cells originating from blood or other tissues; in vitro diagnostic agents, namely, small molecules, polypeptides, antibodies, drugs, or other natural or laboratory-made products for scientific use; pharmaceutical and biochemical substances and preparations, in particular reagents for medical research
  • GS0421: Medical and pharmaceutical research and development; scientific research and development services; industrial research in the field of human biology and human diseases such as cancer, inflammation, and immune disorders; industrial development in the field of human biology and human diseases such as cancer, inflammation, and immune disorders; laboratory services for cell culture, testing, and/or detecting the effects of drugs on cell types, in particular cells originating from blood or other tissues; professional consultancy services in the field of medical and pharmaceutical research and development; contract research services in the field of diagnosis and therapy of cancer, inflammation, and immune disorders; computer programming
Case File Event Statements
  • 10/14/2022 - 2 years ago
    38 - CANCELLED SEC. 8 (6-YR) Type: C8..
  • 7/15/2022 - 2 years ago
    37 - APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Type: CHAN
  • 7/15/2022 - 2 years ago
    36 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA
  • 7/15/2022 - 2 years ago
    35 - TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS Type: ECDR
  • 7/15/2022 - 2 years ago
    34 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA
  • 7/15/2022 - 2 years ago
    33 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP
  • 7/15/2022 - 2 years ago
    32 - TEAS CHANGE OF OWNER ADDRESS RECEIVED Type: COAR
  • 3/29/2021 - 3 years ago
    31 - COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED Type: REM1
  • 3/29/2016 - 8 years ago
    30 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 1/12/2016 - 8 years ago
    29 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 1/12/2016 - 8 years ago
    28 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 12/24/2015 - 9 years ago
    27 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 12/4/2015 - 9 years ago
    26 - LAW OFFICE PUBLICATION REVIEW COMPLETED Type: PREV
  • 11/23/2015 - 9 years ago
    25 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 11/23/2015 - 9 years ago
    24 - EXAMINER'S AMENDMENT ENTERED Type: XAEC
  • 11/23/2015 - 9 years ago
    23 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN
  • 11/23/2015 - 9 years ago
    22 - EXAMINERS AMENDMENT E-MAILED Type: GNEA
  • 11/23/2015 - 9 years ago
    21 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA
  • 11/10/2015 - 9 years ago
    20 - PREVIOUS ALLOWANCE COUNT WITHDRAWN Type: ZZZX
  • 11/3/2015 - 9 years ago
    19 - WITHDRAWN FROM PUB - OG REVIEW QUERY Type: PBCR
  • 10/19/2015 - 9 years ago
    18 - LAW OFFICE PUBLICATION REVIEW COMPLETED Type: PREV
  • 10/14/2015 - 9 years ago
    17 - ASSIGNED TO LIE Type: ALIE
  • 9/14/2015 - 9 years ago
    16 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 8/26/2015 - 9 years ago
    15 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 8/25/2015 - 9 years ago
    14 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 8/25/2015 - 9 years ago
    13 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 6/15/2015 - 9 years ago
    12 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 6/15/2015 - 9 years ago
    11 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 6/15/2015 - 9 years ago
    10 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 5/21/2015 - 9 years ago
    9 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 5/20/2015 - 9 years ago
    8 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 5/20/2015 - 9 years ago
    7 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 11/24/2014 - 10 years ago
    6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 11/24/2014 - 10 years ago
    5 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 11/24/2014 - 10 years ago
    4 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 11/14/2014 - 10 years ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 8/8/2014 - 10 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM Type: NWOS
  • 8/4/2014 - 10 years ago
    1 - NEW APPLICATION ENTERED IN TRAM Type: NWAP